Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection

Four studies under preclinical and clinical conditions were performed to evaluate the efficacy of a new trivalent vaccine against Porcine circovirus 2 (PCV-2) infection. The product contained inactivated PCV-1/PCV-2a (cPCV-2a) and PCV-1/PCV-2b (cPCV-2b) chimeras, plus M. hyopneumoniae inactivated ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleguezuelos, Patricia, Sibila, Marina, Cuadrado-Matías, Raúl, López-Jiménez, Rosa, Pérez, Diego, Huerta, Eva, Pérez, Mónica, Correa-Fiz, Florencia, Mancera-Gracia, José Carlos, Taylor, Lucas P., Borowski, Stasia, Saunders, Gillian, Segalés, Joaquim, López-Soria, Sergio, Balasch, Mònica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414577/
https://www.ncbi.nlm.nih.gov/pubmed/36016122
http://dx.doi.org/10.3390/vaccines10081234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414577/
https://www.ncbi.nlm.nih.gov/pubmed/36016122
http://dx.doi.org/10.3390/vaccines10081234

Ejemplares similares